Management of Recurrent Retroperitoneal Sarcoma.
Joshua S JolissaintChandrajit P RautMark FairweatherPublished in: Current oncology (Toronto, Ont.) (2023)
Recurrence after resection of retroperitoneal sarcoma is common and varies by histological subtype. Pattern of recurrence is similarly affected by histology (e.g., well-differentiated liposarcoma is more likely to recur locoregionally, whereas leiomyosarcoma is more likely to develop distant metastases). Radiotherapy may provide effective locoregional control in limited circumstances and the data on the impact of chemotherapy are scant. Surgery for locally recurrent disease is associated with the greatest survival benefit; however, data are retrospective and from a highly selected subgroup of patients. Limited retrospective data have also suggested a survival association with the resection of limited distant metastases. Given the complexity of these patients, multidisciplinary evaluation at a high-volume sarcoma center is critical.
Keyphrases
- end stage renal disease
- newly diagnosed
- electronic health record
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- lymph node
- big data
- early stage
- randomized controlled trial
- free survival
- atrial fibrillation
- artificial intelligence
- acute coronary syndrome
- coronary artery disease
- machine learning
- clinical trial
- open label
- patient reported outcomes
- rectal cancer
- radiation induced
- phase iii